Primary parathyroid hyperplasia: Difference between revisions
Jump to navigation
Jump to search
Line 37: | Line 37: | ||
==Differentiating type page name here from other Diseases== | ==Differentiating type page name here from other Diseases== | ||
* Prathyroid adenoma | |||
* Parathyroid carcinoma | |||
== Epidemiology and Demographics == | == Epidemiology and Demographics == |
Revision as of 17:00, 7 January 2016
For patient information, click Insert page name here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords:
Overview
Historical Perspective
Classification
- Primary parathyroid hyperplasia
- Secondary parathyroid hyperplasia
Pathophysiology
- Parathyroid hyperplasia is the diffuse enlargement of the parathyroid glands and is a cause of primary hyperparathyroidism.
- In ~50% of cases there is asymmetric enlargement of the parathyroid glands.
Genetics
Associated Conditions
- Multiple endocrine neoplasia I (MEN I)
- Multiple endocrine neoplasia II A (MEN IIA)
- Isolated familial hyperparathyroidism
Gross Pathology
- Classically all parathyroid glands are involved; however, some may be spared making it difficult to differentiate this from parathyroid adenoma.
Microscopic Pathology
- Classically have abundant adipose tissue[1]
- +/-Water-clear cells ("water-clear cell hyperplasia").
Causes
- Primary parathyroid hyperplasia
- Sporadic (80%): associated with exposure to radiation and lithium
- Familial (20%): associated with MEN 1 and MEN 2a
- Secondary parathyroid hyperplasia
- Renal failure
Differentiating type page name here from other Diseases
- Prathyroid adenoma
- Parathyroid carcinoma
Epidemiology and Demographics
Age
Females are more commonly affected with parathyroid hyperplasia than males. The females to male ratio is approximately 3:1.
Gender
Race
Developed Countries
Developing Countries
Risk Factors
- Multiple endocrine neoplasia I
- Multiple endocrine neoplasia II A
- Isolated familial hyperparathyroidism
Screening
Natural History, Complications and Prognosis
- Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as excellent.
Complications
- Kidney stones
- Osteitis fibrosa cystica
Diagnosis
Diagnostic Criteria
If available, the diagnostic criteria are provided here.
History
A directed history should be obtained to ascertain
Symptoms
- Constipation
- Bone fractures or bone pain
- Nausea
- Lethargy
- Muscle pain
Past Medical History=
Family History
Social History
Occupational
Alcohol
The frequency and amount of alcohol consumption should be characterized.
Drug Use
Smoking
Allergies
Physical Examination
Appearance of the Patient
Vital Signs
Skin
Head
Eyes
Ear
Nose
Mouth
Throat
Heart
Lungs
Abdomen
Extremities
Neurologic
Genitals
Other
Laboratory Findings
- Calcium
- Phosphorus
- Magnesium
- PTH
- Vitamin D levels
- A 24-hour urine test
Electrolyte and Biomarker Studies
Electrocardiogram
Chest X Ray
- Bone x-rays
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
- Bone density test (DXA)
- Nuclear medicine (Tc-99m MIBI) is the current modality of choice.
Other Diagnostic Studies
Treatment
Pharmacotherapy
Acute Pharmacotherapies
Chronic Pharmacotherapies
Surgery
- Surgery is the mainstay of treatment for parathyroid hyperplasia. Three and a half part of the glands are removed during surgery.
Indications for Surgery
Pre-Operative Assessment
Post-Operative Management
Transplantation
Primary Prevention
Secondary Prevention
- Genetic screening for patients with family history of MEN syndrome.
Cost-Effectiveness of Therapy
Future or Investigational Therapies
References
- ↑ Parathyroid hyperplasia. Librepathology (2016). http://librepathology.org/wiki/index.php?title=Parathyroid_hyperplasia&redirect=no Accessed on January 7, 2016